URINARY TRYPTAMINE AND INDOLE-3-ACETIC ACID EXCRETION BY SCHIZOPHRENIC PATIENTS: USE OF THE TRYPTAMINE/INDOLE ACETIC ACID RATIO AS AN INDEX OF MONOAMINE OXIDASE INHIBITION.
D000596:Amino Acids / Q000378:metabolism*; D005441:Fluids and Secretions; D005973:Glutamine; D005998:Glycine; D006639:Histidine; D006801:Humans; D007210:Indoleacetic Acids; D007211:Indoles; D007490:Iproniazid; D008660:Metabolism; D008715:Methionine; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors; D010600:Pharmacology; D010649:Phenylalanine; D012559:Schizophrenia; D014363:Tryptamines; D014364:Tryptophan; D014556:Urine
D000596:Amino Acids; D007210:Indoleacetic Acids; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D014363:Tryptamines; D005973:Glutamine; C030820:tryptamine; D010649:Phenylalanine; D006639:Histidine; C030737:indoleacetic acid; D014364:Tryptophan; D008715:Methionine; D007490:Iproniazid; D008995:Monoamine Oxidase; D005998:Glycine
AMINO ACID METABOLISM; EXCRETION; GLUTAMINE; GLYCINE; HISTIDINE; INDOLEACETIC ACID; INDOLES; IPRONIAZID; METABOLISM; METHIONINE; PHARMACOLOGY; PHENYLALANINE; SCHIZOPHRENIA; TRYPTAMINES; TRYPTOPHAN; URINE